Please join Dr. Marcus Neubauer, Chief Medical Officer, The US Oncology Network and Sarah Alwardt, VP Operations, Real World Evidence and Commercial Intelligence at McKesson, as they discuss the impact of the COVID-19 crisis on community oncology practices and the implications for life sciences companies.
They will explore how it is affecting patient access and clinical decisions related to cancer treatment; how life sciences companies can support community oncology during this pandemic; questions which life sciences companies are wrestling with, including the impact on new and existing clinical trials; and what we can learn from the early insights found in McKesson’s iKnowMed oncology EHR data.
Click here for additional information and registration details.
